Diet or optimised medical therapy for people with irritable bowel syndrome - Authors' reply

Affiliations

¹ Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: sanna.nybacka@gu.se.
² Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
³ Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Center for Functional Gastrointestinal and Motility Disorders, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.

Comment

Sanna Nybacka et al. Lancet Gastroenterol Hepatol. 2024 Sep.

. 2024 Sep;9(9):786-787.

doi: 10.1016/S2468-1253(24)00219-X.

¹ Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: sanna.nybacka@gu.se.
² Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
³ Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Center for Functional Gastrointestinal and Motility Disorders, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.

No abstract available

Conflict of interest statement

We declare no competing interests.

Diet or optimised medical therapy for people with irritable bowel syndrome.
Lambiase C, Chiarioni G, Bellini M. Lambiase C, et al. Lancet Gastroenterol Hepatol. 2024 Sep;9(9):785-786. doi: 10.1016/S2468-1253(24)00194-8. Lancet Gastroenterol Hepatol. 2024. PMID: 39127070 No abstract available.